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2214-0247/Copyright ª 2014, TaiwanAbstract Since 1987, cancer has been the leading cause of death in Taiwan. However,
chemotherapy resistance in metastatic cancer is the major obstacle to effectively treat can-
cers. To solve this problem, understanding the mechanism of metastasis is critical. In this
study, we used a transwell system to select a metastatic subpopulation from the human lung
cancer cell line A549. The invasive and migratory activities of this cell line were analyzed with
transwell selection and wound healing assay, respectively. Moreover, migration-stimulating
factors, such as SNAI-1 and mPR, were detected with Western blotting. In comparison to
A549, enhanced invasiveness, motility, and migration-stimulating factor expression were
observed in the invasive lung cancer cell line A549-I5. These cell lines provide a useful tool
for the further study of the biologic properties of lung cancer in vitro.
Copyright ª 2014, Taiwan Genomic Medicine and Biomarker Society. Published by Elsevier
Taiwan LLC. All rights reserved.Introduction
Metastases are the major cause of death from cancer.
Finding the biomarker of metastasis is therefore considered
an urgent matter. Some studies have shown certain proteinsof Applied Science, National
umber 521, Nan-Da Road,
e.edu.tw (H.-C.Chou).
4.07.002
Genomic Medicine and Biomarkeras biomarkers of metastasis. For example, receptor
tyrosine-protein kinase erbB-2 (ERBB2) amplification/over-
expression is associated with metastasis in breast cancer,1
whereas caveolin-1 (CAV1) is associated with enhanced
metastasis in melanomas.2 However, researchers have not
found the biomarker of all aggressive cancers. Previously,
our laboratory indicated that the expression of mPR in the
invasive oral cancer cell line OC3-I5 is 2.4 times more than
that in the noninvasive oral cancer cell line OC3. The mPR
protein [progesterone receptor membrane component 1
(PGRMC-1)] is a major receptor of progesterone and is alsoSociety. Published by Elsevier Taiwan LLC. All rights reserved.
160 M.-W. Lin et al.a heme-binding protein.3,4 Previous studies have shown
that the overexpression of mPR occurs as ovarian cancer,
breast cancer, or uterine sarcoma starts to go out of con-
trol.5e7 As our laboratory has found overexpressed mPR in
certain invasive cancer lines, it is interesting to figure out
whether mPR is truly a universal biomarker of cancer
metastasis in highly invasive lung cancer cells. The
expression of zinc finger protein SNAI1, a family of
transcriptional repressors implicated in regulating
epithelialemesenchymal transition (EMT)-associated can-
cer cell migration,8 has also been observed in this study.
Materials and methods
Cell line, cell culture, and transwell selection
The A549 cell line was maintained in Dulbecco modified
Eagle’s medium (Gibco, Waltham, MA, USA) supplemented
with 10% (v/v) bovine serum (FBS; Gibco), and 1% (v/v)
antibiotics (penicillinestreptomycin). Cells were seeded in
the chambers of 24-well plates (SPL Life Sciences,
Pocheon-City, Gyeonggi-Do, South Korea) (5  104 cells/
well), and we coated 50 mL matrigel (Becton, Dickinson and
Company, Franklin Lakes, NJ, USA) as the extracellular
matrix in each chamber. There is serum-free medium in the
chambers; there is complete medium under the chambers.
The difference in serum concentration triggered cells to
invade through the polyethylene tetraphthalate mem-
brane, and then these cells became more invasive
compared to the original A549. These selected cells are
named A549-I5.
Invasion assay
We used transwell selection to select the highly invasive
cell line. Consequently, crystal violet was used to stain the
invasive cells that were adhered onto the polyethylene
tetraphthalate membrane of the insert chamber.
Wound healing
Cells were seeded in 12-well plates (5  104 cells/well). A
pipette tip was used to make a straight scratch, simulating
a wound. Cells were starved in serum-free medium for 56Figure 1 Using transwell selection to generate highly invasive ce
cells.hours to prevent cell proliferation. Cell migration was
observed every 8 hours, and the gap width was measured.
Western blot for SNAI-1 and mPR
Cells were washed in 0.5 phosphate buffered saline and
scraped in 1 NP40, and then the protein was extracted by
centrifugation. Bradford assay was used to quantify the
protein, and the protein samples were diluted with the
sample buffer and separated by 10% sodium dodecyl sulfa-
teepolyacrylamide gel electrophoresis. Gel-separated pro-
teins were electroblotted onto polyvinylidene difluoride
membranes, and then the membranes were blocked by 5%
bovine serum albumin in Tris-buffered saline with 0.1%
Tween 20 (TBS-T) for 1 hour. Membranes were incubated
overnight with primary antibody solution in TBS-T, and
washedwith tris-buffered saline and TBS-T (5 10minutes).
After washing, the membranes were incubated with a sec-
ondary antibody for 1 hour and washed again with TBS-T
(5  10 minutes). Immunoreactive proteins were visualized
using the enhanced chemiluminescence method (BioVision,
Mountain View, CA, USA).
Statistical analysis
Statistical analyses were performed using two-tailed Stu-
dent t test. A p value < 0.05 was considered statistically
significant.
Results
Transwell selection
Transwell selection was used to generate the highly inva-
sive cell line. The morphology of the highly invasive cell line
(A549-I5) cells is more circular than that of the noninvasive
cell line (A549) cells. We assume that the changes in cell
morphology would promote cell migration ability (Fig. 1).
Invasion assay
Transwell invasion assay has been widely used for studying
tumor cell invasion. The invaded cells can be quantified
using crystal violet staining. Because more A549-I5 cellsll line. (A) Morphology of A549 cells. (B) Morphology of A549-I5
Figure 2 Quantification of invaded cells using crystal violet staining. (A) A549 stained by crystal violet. (B) A549-I5 stained by
crystal violet.
Figure 3 Migratory ability of A549 and A549-I5 cells. Cell migration was observed, and width of gap was measured every 8 hours.
Figure 4 Expression of (A) SNAI-1 and (B) mPR protein was detected in A549 and A549-I5 cells using Western blotting, and GAPDH
(glyceraldehyde-3-phosphate dehydrogenase) was used as the loading control. *p < 0.05 indicates statistical significance.
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capacity of A549-I5 is higher than that of the noninvasive
cell line, A549 (Fig. 2).
Wound healing
By observing the cells every 8 hours, we found that the gap
width of A549-I5 cells decreased more significantly than
that of A549 cells. We assumed that the migratory ability
and wound healing ability of A549-I5 is superior to nonin-
vasive cell line A549 (Fig. 3).
Western blot
To affirm the invasive ability of A549-I5, we detected the
expression of SNAI-1 and mPR using Western blotting.
SNAI-1 is the biomarker of the EMT pathway, and the
overexpression of SNAI-1 is associated with metastasis9;
moreover, a high expression of mPR is related to cancer
stage.5e7 Accordingly, the expression of SNAI-1 in A549-I5
was 1.98 times than that in A549 (p Z 0.0315), and the
expression of mPR in A549-I5 was 2.37 times than that in
A549 (p Z 0.0795; Fig. 4).
Discussion
Most cells are heterogeneous, and so are cancer cells. The
tumorigenic subpopulation could be serially passaged and
contains the preferential resistance to chemotherapy and
radiotherapy. By using of transwell culture system, the
advanced cell line A549-I5 with greater metastatic potential
has been selected. In addition to SNAI-1, mPR has been
shown to be upregulated in A549-I5. As previous studies have
shown that SNAI-1 and mPR are related to the progression of
cancer stages and drug resistance,5e7 it is helpful to use ourcell model to understand the role of SNAI-1 or mPR in the
development of cancer metastasis as well as to discover
other metastatic biomarkers through proteomics.
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